Hepatitis disease progression can be very serious. Learn how doctors treat different types of hepatitis, and how to protect yourself against infection.
CompassBiotech Making Drugs to Combat Major Human Diseases EDMONTON, Sept. 26, 2011 /PRNewswire/ - Compass (COBI:OB) is pleased to announce new research findings that it believes will alter the course of HCV vaccine development and other vaccines in gener
CompassBiotech Making prescription drugs affordable EDMONTON, Sept. 27, 2011 /PRNewswire/ - Compass Biotechnologies (COBI:OB) is a product-oriented specialty biotechnology company focused on offering products for multi-billion dollar markets. The compan
Patients with non-alcoholic fatty liver disease (NAFLD) with advanced fibrosis or cirrhosis have a lower incidence of liver-related complications and hepatocellular carcinoma (HCC) than patients infected with hepatitis C virus (HCV), according to the pros
Making prescription drugs affordable EDMONTON, Sept. 28, 2011 /PRNewswire/ - Compass Biotechnologies, Inc. (COBI: OB) prepares to market, sell and distribute recombinant human cytokines and growth factors for research purposes. Further to the recent annou
Patients being treated for chronic hepatitis C become less likely to take their medications over time, according to a new study from the Perelman School of Medicine at the University of Pennsylvania.